Development of a brain-penetrant G9a methylase inhibitor to target Alzheimer’s disease-associated proteopathology
Cited by 7
Related Papers
Prolyl hydroxylation by EglN2 destabilizes FOXO3a by blocking its interaction with the USP9x deubiquitinase
|Genes & Development|2014|134
Prolyl hydroxylase substrate adenylosuccinate lyase is an oncogenic driver in triple negative breast cancer
|Nature Communications|2019|48